ID
35149
Description
Evaluate the Impact of Afatinib on Quality of Life and Symptom Burden of Greek Subjects With Advanced NSCLC in Routine Patient Care Settings; ODM derived from: https://clinicaltrials.gov/show/NCT02440854
Lien
https://clinicaltrials.gov/show/NCT02440854
Mots-clés
Versions (1)
- 19/02/2019 19/02/2019 -
Détendeur de droits
See clinicaltrials.gov
Téléchargé le
19 février 2019
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Carcinoma, Non-Small-Cell Lung NCT02440854
Eligibility Carcinoma, Non-Small-Cell Lung NCT02440854
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Afatinib | Therapeutic procedure Initiation Before Enrollment
Type de données
boolean
Alias
- UMLS CUI [1]
- C2987648
- UMLS CUI [2,1]
- C0087111
- UMLS CUI [2,2]
- C1704686
- UMLS CUI [2,3]
- C0332152
- UMLS CUI [2,4]
- C1516879
Description
Medical contraindication Investigational New Drugs
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C1301624
- UMLS CUI [1,2]
- C0013230
Description
Investigational New Drugs
Type de données
boolean
Alias
- UMLS CUI [1]
- C0013230
Similar models
Eligibility Carcinoma, Non-Small-Cell Lung NCT02440854
- StudyEvent: Eligibility
C0029921 (UMLS CUI [2])
C0001779 (UMLS CUI [3])
C0205179 (UMLS CUI [1,2])
C1517927 (UMLS CUI [1,3])
C3258246 (UMLS CUI [1,4])
C0278987 (UMLS CUI [2,1])
C3258246 (UMLS CUI [2,2])
C2984891 (UMLS CUI [3])
C0332197 (UMLS CUI [1,2])
C2114399 (UMLS CUI [1,2])
C0525058 (UMLS CUI [2])
C0087111 (UMLS CUI [2,1])
C1704686 (UMLS CUI [2,2])
C0332152 (UMLS CUI [2,3])
C1516879 (UMLS CUI [2,4])
C0013230 (UMLS CUI [1,2])